DOJ

Inari Medical, Inc. (NARI) Plummets on News of DOJ Investigation – Hagens Berman

Retrieved on: 
Monday, March 18, 2024
NARI, Health, Piper Sandler Companies, SAN, News, Person, Disclosure, DOJ, Justice, Hagens Berman

SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now .
  • Inari Medical shares recently tumbled after the commercial-stage medical device company disclosed it was being investigated by the DOJ over certain payments to healthcare professionals.
  • But on Feb. 29, 2024, the true drivers of Inari’s revenue growth came into question, when Inari revealed that federal regulators had initiated an investigation into its payments to Health Care Professionals (“HCPs”) sometime during Dec. 2023.
  • This news sent the price of Inari shares crashing $12.14, or down about 21%, on Feb. 29, 2024.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UnitedHealth Group Incorporated - UNH

Retrieved on: 
Friday, March 15, 2024
UnitedHealth Group, WSJ, Optum, News, DOJ, Pomerantz, UNH, The Wall Street Journal

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH).

Key Points: 
  • NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH).
  • 7980
    The investigation concerns whether UnitedHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On February 27, 2024, The Wall Street Journal (“WSJ”) reported that the U.S. Department of Justice (“DOJ”) has launched an antitrust investigation into UnitedHealth.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health, Inc. - CYH

Retrieved on: 
Friday, March 15, 2024
CYH, Community, Manager, Community health, News, LLP, DOJ, Annual report, Dialysis, Pomerantz

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Community Health, Inc. (“Community Health” or the “Company”) (NYSE: CYH).

Key Points: 
  • NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Community Health, Inc. (“Community Health” or the “Company”) (NYSE: CYH).
  • The investigation concerns whether Community Health and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTC

Retrieved on: 
Friday, March 15, 2024
Zio, Form FDA 483, Letter, Patient, Ext, LLP, News, DOJ, Complaint, Pomerantz, Action Replay, FDA, Court, IRTC, Cryptocurrency

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC).

Key Points: 
  • NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC).
  • The class action concerns whether iRhythm and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • You have until April 8, 2024, to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired iRhythm securities during the Class Period.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Cummins Inc. - CMI

Retrieved on: 
Friday, March 15, 2024
Certification, Prior, Biophysical environment, News, Ext, LLP, DOJ, Complaint, Pomerantz, Action Replay, Court

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cummins Inc. (“Cummins” or the “Company”) (NYSE: CMI).

Key Points: 
  • NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cummins Inc. (“Cummins” or the “Company”) (NYSE: CMI).
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • The class action concerns whether Cummins Solutions and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, and Amplitude and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, March 15, 2024
Bitcoin, Research, Amplitude, Zio, Bankruptcy, Boston Scientific, J. P. Morgan, Growth, Acceleration, Atrial fibrillation, COVID-19, Patient, Subpoena duces tecum, Defendant, Stroke, News, Data mining, DOJ, Heart failure, Hut 8, P.C, Justice, Marketing, FDA, IRTC, ECG, Mergers and acquisitions, Cryptocurrency

The Company’s principal product is a monitoring patch that provides electrocardiogram (“ECG”) monitoring for up to 14 days, called Zio XT.

Key Points: 
  • The Company’s principal product is a monitoring patch that provides electrocardiogram (“ECG”) monitoring for up to 14 days, called Zio XT.
  • The Zio XT is intended for non-critical patients, as it does not provide real-time reporting.
  • These types of heart monitors that are approved for high-risk patients and provide near real-time alerts are also referred to as “real-time” monitors.
  • As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

Retrieved on: 
Thursday, March 14, 2024
Zio, Advertising, Boston Scientific, J. P. Morgan, Growth, Patient, Subpoena duces tecum, LLP, DOJ, Justice, Marketing, FDA, Court, IRTC, Pharmaceutical industry

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

Key Points: 
  • Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
  • As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding iRhythm’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

FINAL DEADLINE REMINDER FOR CMI INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead Plaintiff Deadline in Securities Class Action Lawsuit Filed Against Cummins Inc. (CMI)

Retrieved on: 
Thursday, March 14, 2024
Certification, IRS, District court, Lead, CFTC, LLP, COPY, News, RAM, DOJ, CMI, EPA, Fraud, Medicare, Court, Person, Pharmaceutical industry

The action charges Cummins with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.

Key Points: 
  • The action charges Cummins with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects.
  • As a result of Cummins’ s materially misleading statements and omissions to the public, Cummins’ s investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Cummins investors who have suffered significant losses to contact the firm directly to acquire more information.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.

U. S. Steel Consent Decree for Clairton Plant Incidents Authorized by Environmental Protection Agency and Department of Justice

Retrieved on: 
Tuesday, March 26, 2024
Environment, Manufacturing, Environmental Issues, Green Technology, Environmental Health, Steel, Allegheny County, Pennsylvania, Consent, Letter, U.S. Steel, U.S. EPA, Public, Consent decree, Edgar Thomson Steel Works, DOJ, Plant, Clairton, Pennsylvania, Coke, Monongahela River, United States district court, Hydrogen, Safety, Economic development, Iron

United States Steel Corporation (NYSE: X) has received authorization for its multi-million-dollar Consent Decree from the United States Environmental Protection Agency (U.S. EPA) and the United States Department of Justice (DOJ).

Key Points: 
  • United States Steel Corporation (NYSE: X) has received authorization for its multi-million-dollar Consent Decree from the United States Environmental Protection Agency (U.S. EPA) and the United States Department of Justice (DOJ).
  • The January 2024 Consent Decree with the Allegheny County Health Department, Clean Air Council, and PennEnvironment addressed the Clairton Plant fire in 2018, and power outages at the Plant in 2019 and 2022.
  • Project funds will be managed and distributed by the Jefferson Regional Foundation and Allegheny County Department of Economic Development.
  • On March 20, 2024, DOJ issued a letter stating that they had no objections to the Consent Decree.

Gibbs Law Group Files Class Action Lawsuit on Behalf of Healthcare Providers Harmed by Change Healthcare Data Breach

Retrieved on: 
Tuesday, March 19, 2024
Class Action Lawsuit, Professional Services, Legal, UnitedHealth Group, Computer, Health, Patient, Pharmacy, Associated Press, Hospital, Health care, Acquisition, Change Healthcare, Press, Insurance, American Hospital Association, DOJ, AHA, System, FBI, Eric Gibbs, Hearing, Cryptocurrency

On March 18, 2024, Gibbs Law Group filed a class action lawsuit against Change Healthcare Inc., Optum, Inc. and UnitedHealth Group Incorporated following a massive data breach that has disrupted critical infrastructure in the U.S. healthcare system since February 21, 2024.

Key Points: 
  • On March 18, 2024, Gibbs Law Group filed a class action lawsuit against Change Healthcare Inc., Optum, Inc. and UnitedHealth Group Incorporated following a massive data breach that has disrupted critical infrastructure in the U.S. healthcare system since February 21, 2024.
  • The lawsuit was filed on behalf of healthcare providers whose use of Change Healthcare’s services was disrupted due to the data breach and related shutdown of the Change Healthcare computer networks.
  • Affected healthcare providers have been unable to get paid on claims for medical services they have provided since the breach occurred.
  • Healthcare providers who believe they were impacted by the Change Healthcare data breach should contact our legal team for a free case evaluation by calling 510-369-0259 or visiting our website: Change Healthcare Class Action Lawsuit .